Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Investigational New Drugs|October 21, 2006
A phase I/II trial of celecoxib with chemotherapy and radiotherapy in the treatment of patients with locally advanced oesophageal cancerS J Dawson, M Michael, J Biagi, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|August 19, 2021
Demographic and lifestyle risk factors for gastroesophageal reflux disease and Barrett's esophagus in AustraliaSabrina E Wang, Bradley J Kendall, Allison M Hodge, et al.
Breast Cancer Research and Treatment|February 13, 2017
The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancerJ S Thomas, A M Hanby, N Russell, et al.
Physical Review Letters|June 1, 2004
Is the nuclear spin-orbit interaction changing with neutron excess?J P Schiffer, S J Freeman, J A Caggiano, et al.
Breast Cancer Research and Treatment|October 14, 2010
The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative studyE J Macaskill, J M S Bartlett, V S Sabine, et al.
Physical Review Letters|February 14, 2012
Test of sum rules in nucleon transfer reactionsJ P Schiffer, C R Hoffman, B P Kay, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
Mechanisms for the Sex-Specific Effect of H. Pylori on Risk of Gastroesophageal Reflux Disease and Barrett's EsophagusSabrina E Wang, S Ghazaleh Dashti, Allison M Hodge, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2021
Factors Explaining Socio-Economic Inequalities in Survival from Colon Cancer: A Causal Mediation AnalysisNina Afshar, S Ghazaleh Dashti, Luc Te Marvelde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinomaKate H Brettingham-Moore, Cuong P Duong, Danielle M Greenawalt, et al.
ESMO Open|April 19, 2024
A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutationsJ Rodon, E Rodriguez, M L Maitland, et al.
Pageof 9